Status:
RECRUITING
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
The Canadian College of Naturopathic Medicine
Lotte & John Hecht Memorial Foundation
Conditions:
Lung Cancer
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Despite enormous advances in thoracic surgery and oncology, two critical issues concern patients undergoing curative-intent surgery for lung, gastric and esophageal cancer: first, a majority (\~60%) o...
Eligibility Criteria
Inclusion
- Inclusion criteria
- • Adults eligible for complete resection of lung, gastric or esophageal cancer
- Exclusion criteria
- Small cell, carcinoid, or gastrointestinal stromal (GIST) tumours
- Any wedge resections of lung cancer
- History of cancer with active treatment in the last 3 years (not including superficial bladder cancer or non-melanoma skin cancer)
- Patients currently receiving care guided by an ND or who have previously seen an ND in the last 3 months
- Pregnant or breastfeeding women\*
- Any reason which, in the opinion of the Principal Investigator (or delegate), would prevent the subject from participating in the study
- Use of an investigational drug or participation in an investigational study within 30 days prior to starting the study
Exclusion
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04871412
Start Date
April 4 2022
End Date
December 1 2029
Last Update
April 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
2
Michael Garron Hospital
Toronto, Ontario, Canada, M4C 3E7